within Pharmacolibrary.Drugs.ATC.S;

model S01AA15
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00125,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01AA15</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dihydrostreptomycin is an aminoglycoside antibiotic that was historically used for the treatment of tuberculosis and infections caused by gram-negative bacteria. Due to significant side effects, including ototoxicity and nephrotoxicity, as well as the development of resistance, it is rarely used in modern clinical practice and is not approved for human use in many regions.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic model parameters for dihydrostreptomycin with specific values were found. Estimates are provided based on its close similarity to streptomycin and general aminoglycoside pharmacokinetic properties in healthy adults.</p><h4>References</h4><ol><li><p>Groen, K, Pereboom-De Fauw, DP, Van Veen-Rutgers, A, Vulto, AG, &amp; De Neeling, AJ (1996). Bioavailability in the rabbit of penicillin and dihydrostreptomycin from three commercial penicillin/aminoglycoside fixed combination products for intramuscular injection. <i>Journal of veterinary pharmacology and therapeutics</i> 19(5) 364–369. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2885.1996.tb00065.x&quot;>10.1111/j.1365-2885.1996.tb00065.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8905570/&quot;>https://pubmed.ncbi.nlm.nih.gov/8905570</a></p></li><li><p>Groen, K, Mevius, DJ, Pereboom-De-Fauw, DP, DeNeeling, AJ, &amp; Vulto, AG (1996). Bioequivalence study in calves of three commercial penicillin/dihydrostreptomycin fixed combination products for intramuscular injection. <i>Journal of veterinary pharmacology and therapeutics</i> 19(5) 370–375. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2885.1996.tb00066.x&quot;>10.1111/j.1365-2885.1996.tb00066.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8905571/&quot;>https://pubmed.ncbi.nlm.nih.gov/8905571</a></p></li><li><p>Nouws, JF, &amp; König, CD (1983). Penetration of some antibiotics into the lacrimal fluid of sheep. <i>The veterinary quarterly</i> 5(3) 114–121. DOI:<a href=&quot;https://doi.org/10.1080/01652176.1983.9693884&quot;>10.1080/01652176.1983.9693884</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6636501/&quot;>https://pubmed.ncbi.nlm.nih.gov/6636501</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01AA15;
